Studies of neural metabolism reveal our brain’s effort to keep us alive and the evolutionary constraints that sculpted our ...

As an Alzheimer’s caregiver writes, a biomarker test was recently approved by the FDA and can lead to earlier treatment.

The Food and Drug Administration (FDA) cleared the first blood test recently to help diagnose Alzheimer's disease.

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

FDA approves first blood test for Alzheimer's detection. Simple blood draw replaces expensive scans and spinal taps.

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

The results were clear: people with early Parkinson’s had higher levels of TSPO in their brains compared to people without ...

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.